These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 31089072)

  • 21. New Diagnostic Criteria of Polycystic Ovarian Morphology for Adolescents: Impact on Prevalence and Hormonal Profile.
    Merino PM; Villarroel C; Jesam C; López P; Codner E
    Horm Res Paediatr; 2017; 88(6):401-407. PubMed ID: 29049986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
    Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type 1 Diabetes and Polycystic Ovary Syndrome: Systematic Review and Meta-analysis.
    Escobar-Morreale HF; Roldán-Martín MB
    Diabetes Care; 2016 Apr; 39(4):639-48. PubMed ID: 27208367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How polycystic ovary syndrome came into its own.
    Azziz R
    F S Sci; 2021 Feb; 2(1):2-10. PubMed ID: 35559761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic Syndrome in Adolescents with Polycystic Ovary Syndrome: Prevalence on the Basis of Different Diagnostic Criteria.
    Akgül S; Bonny AE
    J Pediatr Adolesc Gynecol; 2019 Aug; 32(4):383-387. PubMed ID: 30710625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of the polycystic ovary syndrome in female residents of Chengdu, China.
    Zhuang J; Liu Y; Xu L; Liu X; Zhou L; Tang L; Kang D; Guo W; He M; Yang F; Qiu D
    Gynecol Obstet Invest; 2014; 77(4):217-23. PubMed ID: 24751759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Introduction: Determinants of polycystic ovary syndrome.
    Azziz R
    Fertil Steril; 2016 Jul; 106(1):4-5. PubMed ID: 27238627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. To what extent does the use of the Rotterdam criteria affect the prevalence of polycystic ovary syndrome? A community-based study from the Southwest of Iran.
    Rashidi H; Ramezani Tehrani F; Bahri Khomami M; Tohidi M; Azizi F
    Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():100-5. PubMed ID: 24411130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of PCOS phenotypes in adolescent and young adult Mediterranean women with possible PCOS.
    Fruzzetti F; Baldari F; Palla G; Fidecicchi T; Carmina E
    J Endocrinol Invest; 2021 May; 44(5):995-1000. PubMed ID: 32839937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria.
    Franks S
    J Clin Endocrinol Metab; 2006 Mar; 91(3):786-9. PubMed ID: 16418209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PCOS: a diagnostic challenge.
    Azziz R
    Reprod Biomed Online; 2004 Jun; 8(6):644-8. PubMed ID: 15169578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.
    Lujan ME; Jarrett BY; Brooks ED; Reines JK; Peppin AK; Muhn N; Haider E; Pierson RA; Chizen DR
    Hum Reprod; 2013 May; 28(5):1361-8. PubMed ID: 23503943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria.
    Shroff R; Syrop CH; Davis W; Van Voorhis BJ; Dokras A
    Fertil Steril; 2007 Nov; 88(5):1389-95. PubMed ID: 17462641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.
    Bhide P; Kulkarni A; Dilgil M; Dhir P; Shah A; Gudi A; Homburg R
    Gynecol Endocrinol; 2017 Oct; 33(10):801-806. PubMed ID: 28454499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using the androgen excess-PCOS society criteria to diagnose polycystic ovary syndrome and the risk of metabolic syndrome in adolescents.
    Roe AH; Prochaska E; Smith M; Sammel M; Dokras A
    J Pediatr; 2013 May; 162(5):937-41. PubMed ID: 23260096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of polycystic ovary syndrome (PCOS) among reproductive age women from Kashmir valley: A cross-sectional study.
    Ganie MA; Rashid A; Sahu D; Nisar S; Wani IA; Khan J
    Int J Gynaecol Obstet; 2020 May; 149(2):231-236. PubMed ID: 32080845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence, clinical characteristics, and reproductive outcomes of polycystic ovary syndrome in older women referred for tertiary fertility care.
    Tannus S; Tan J; Son WY; Dahan MH
    Arch Gynecol Obstet; 2018 Apr; 297(4):1037-1042. PubMed ID: 29289990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features.
    Welt CK; Gudmundsson JA; Arason G; Adams J; Palsdottir H; Gudlaugsdottir G; Ingadottir G; Crowley WF
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4842-8. PubMed ID: 17003085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic characteristics and metabolic risk factors of cases with polycystic ovary syndrome during adolescence.
    Sıklar Z; Berberoğlu M; Çamtosun E; Kocaay P
    J Pediatr Adolesc Gynecol; 2015 Apr; 28(2):78-83. PubMed ID: 25850587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.